
doi: 10.1038/422341a
pmid: 12646927
The route to new therapeutics often ends in costly failure. The secret of success is the rapid and accurate identification of drug targets with true potential, says Caitlin Smith.
Proteomics, Binding Sites, Drug Industry, Drug Evaluation, Preclinical, Reproducibility of Results, Substrate Specificity, Pharmaceutical Preparations, Animals, Humans, Computer Simulation, Gene Deletion, Software
Proteomics, Binding Sites, Drug Industry, Drug Evaluation, Preclinical, Reproducibility of Results, Substrate Specificity, Pharmaceutical Preparations, Animals, Humans, Computer Simulation, Gene Deletion, Software
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 39 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
